Affordable Access

Publisher Website

Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients.

Authors
Type
Published Article
Journal
International Journal of Cancer
1097-0215
Publisher
Wiley Blackwell (John Wiley & Sons)
Publication Date
Volume
129
Issue
1
Pages
143–150
Identifiers
DOI: 10.1002/ijc.25669
PMID: 20830705
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments